Sakmon, Rasil .
HRN: 20-19-11 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/10/2022
07/17/2022
IVT
170
Q6
Fracture Open Complete Displaced Oblique Tibia Fibula M3rd R
Waiting Final Action
Indication: Prophylaxis Type of Infection: BloodstreamBone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes